4/27 RegenMD

RegenMD         UCLA Cancer Researchers Identify Cell Origin of Squamous Cell Carcinoma April 26, 2011 at 6:08 PM   By Anna Azvolinsky, PhD | April 26, 2011 Scientists at UCLA's Jonsson Comprehensive Cancer Center and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research have identified that squamous cell carcinomas can originate from hair ... See all stories on this topic »         Regenerative medicine startup Juventas completes phase 1 heart failure trial April 26, 2011 at 2:14 PM   Cleveland Clinic spinoff Juventas Therapeutics has successfully completed a phase 1 clinical trial of its regenerative medicine technology in heart failure patients. Cleveland-based Juventas' technology, JVS-100, works by recruiting stem cells from the ... See all stories on this topic »         ACT's Chief Scientific Officer Robert Lanza, M.D., to Deliver Speech at 3rd ... April 26, 2011 at 10:08 AM   In addition to these two FDA-cleared clinical trials, Dr. Lanza will discuss several other early potential hESC- and iPS cell-based therapies that ACT and its joint venture - Stem Cell and Regenerative Medicine International (SCMRI) - are researching, ... See all stories on this topic »         Juventas Therapeutics Completes Successful Phase I Clinical Trial for JVS-100 ... April 26, 2011 at 8:23 AM   CLEVELAND, April 26, 2011 /PRNewswire/ -- Juventas Therapeutics, a clinical-stage regenerative medicine company developing novel therapies for cardiovascular disease, announces that it has successfully completed its Phase I clinical trial evaluating ... See all stories on this topic »         The use of human embryonic stem cells in drug discovery. April 26, 2011 at 3:52 AM   The use of human embryonic stem cells in drug discovery. Clin Pharmacol Ther. 2011 May;89(5):641-3 Authors: Esteso P, Gearhart JD PMID: 21512522 [PubMed - in process]             This email was sent to regenmd@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here